Veterans Affairs patients with diabetes
A stratified Cox proportional hazards model was used, with treatment as a fixed effect and trial-level cardiovascular risk as the stratification factor, to estimate hazard ratios (HRs) and confidence intervals (CIs) when comparing tirzepatide to the control
Its designed for users committed to a yearlong reset
Significant adverse events related to injection site reactions should be reported to the FDA MedWatch program (www.fda.gov/medwatch) in addition to informing the prescribing healthcare provider
However, individual case reports do exist documenting semaglutide-associated pancreatitis, sometimes with dramatically elevated lipase levels (above 3,000 U/L in some cases)
Patients taking either form of the medication may experience some of these common gastrointestinal side effects, especially when first starting treatment or increasing the dose: Nausea Diarrhea Constipation Vomiting These side effects are usually mild to moderate and tend to improve over time as your body adjusts